Event Overview

Now celebrating its 40th year, the FT Global Pharmaceutical and Biotechnology Conference is the essential annual event for pharma-healthcare professionals keen to explore fresh ideas in areas like drug discovery, clinical trials, market access, manufacturing and supply chains.

The conference will feature an unrivalled line-up of senior public and private sector speakers from all over the world. Together they will share insights on how to reshape product lifecycles through innovation and collaboration, blazing the trail for a new era for healthcare.

Digitally connect with over 2,000 of the most influential players in the global pharma-bio industry

Hear from industry decision-makers as leading pharmaceutical CEOs debate about the effects of Covid-19 online

Built upon a 39-year track record of trusted and successful healthcare conferences

Three days of FT-curated content designed to help re-shape the pharma pipeline for growth

Bringing a unique digital dimension to pharma-bio’s premier industry event

CEO, PharmaBoardroom
“Great organisation, well thought and engaging event. A must for global healthcare and life science leaders.”

Previous speakers included:

Bélén Garijo,

CEO - Healthcare,

Merck

Paul Hudson,

CEO,

Sanofi

Sarah Wilkinson,

CEO,

NHS Digital

Susanne Schaffert,

President - Oncology,

Novartis

José Baselega,

Executive Vice President - R&D,

AstraZeneca

Alex Borisy,

Founder, Chairman and CEO,

EQRx

2000+ Attendees
50+ Speakers
1000+ Companies represented
300m+ Social media reach